Signifier Receives FDA Nod to Remove Certain Contraindications for eXciteOSA
The FDA approved Signifier’s request to remove certain contraindications for its daytime sleep apnea therapy device, a “milestone” approval Signifier says will allow greater patient reach.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed